In developed countries, clinical pharmacists perform various activities depending on the available resources and the health system, and TDM represents one of the fundamental responsibilities, this activity is performed according to the specific pharmacotherapy of the patient, and includes the evolution of the disease, risk factors and treatment goals. In Mexico, the practice of clinical pharmacy, is a relatively new discipline, and there is not yet a specialized service that performs monitoring in which pharmacokinetic concepts are applied. Therefore, it is highly important to promote the integration and participation of hospital clinical pharmacists in the individualization of pharmacological therapies, and to acknowledge the benefits that all this provides.
CITATION STYLE
Ana Luisa Robles-Piedras, & Alejandro Chehue-Romero. (2023). Role of the clinical pharmacist in therapeutic drug monitoring: Mexico’s current situation. GSC Biological and Pharmaceutical Sciences, 22(1), 122–124. https://doi.org/10.30574/gscbps.2023.22.1.0481
Mendeley helps you to discover research relevant for your work.